Healthy Skepticism Library
Items published during the years 1980 to 1989
There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.
Page 5 of 11 pages ‹ First < 3 4 5 6 7 > Last ›
HSL3482
MLAM letter follow up—Pfizer
1987 Feb; 2
HSL3483
MLAM letter follow up—Scanpharm
1987 Feb; 2
HSL3502
Re: the promotion of co-dergocrine
1987 Feb;
HSL3503
Re: the promotion of loperamide
1987 Feb;
HSL9600
Perri M.
Direct approach
Pharmaceutical Executive 1987 Feb; 7:35, 38, 40, 42
HSL9617
PMA surveys MDs on sampling
American Druggist 1987 Feb; 195:120
HSL20238
Leippe, MR, Elkin RA
When Motives Clash: Issue Involvement and Response Involvement as Determinants of Persuasion
Journal of Personality and Social Psychology 1987 Feb; 52:(2):269-278
http://psycnet.apa.org/index.cfm?fa=buy.optionToBuy&id=1987-15552-001
HSL3413
Pharmaceutical funds for clinical research: a mixed blessing.
Lancet. 1987 Jan 31; 1:(8527):257-8
HSL3476
Wilmshurst P.
An investigation by the ABPI (Association of the British Pharmaceutical Industry)
Lancet. 1987 Jan 10; 1:(8524):104
HSL19894
Herxheimer A, Collier J
Medicine and the Law: Roussel Convicted of Misleading Promotion
The Lancet 1987 Jan 10; 113-114:
http://www.nelm.nhs.uk/en/NeLM-Area/Evidence/Medicines-Management/References/1987---January/01/Roussel-convicted-of-misleading-promotion/
HSL20504
Herxheimer A
Basic information that prescribers are not getting about drugs
The Lancet 1987 Jan 3; 329:(8523):31-33
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2887%2990713-6/fulltext
HSL3480
Hoechst a cause of illness? The pharmabusiness in the Third World
1987 Jan;
HSL9610
Maddock PH.
Pharmacy in Colombia
International Pharmacy Journal 1987 Jan-Feb; 1:
HSL9620
Kaplan A, Becker R.
Labeling or scientific exchange
Pharmaceutical Executive 1987 Jan; 7:56-58
HSL13249
Alba JW, Hutchinson JW.
Dimensions of Consumer Expertise
Journal of Consumer Research 1987 Jan; 13:(4):411-454
http://www.journals.uchicago.edu/doi/abs/10.1086/209080
HSL2311
Blondeel L, Cannoodt L, DeMeyeere M, Proesmans H
Prescription behaviour of 358 Flemish general practitioners.
1987
HSL3411
Conviction for breach of Medicines Act in drug advertisement
Lancet 1987; 1:57
HSL3412
Paediatricians get their skates on
Lancet 1987; 2:735
HSL3414
Roussel appeal against advertisement decision
Lancet 1987; 1:233
HSL3415
Bennett JC.
The reply
American Journal of Medicine 1987; 83:812
HSL3418
Burley D, Parr G.
Role of the pharmaceutical industry in major clinical trials
Lancet 1987; 2:1464-1465
HSL3419
Chotiner G.
Response
Journal of the American Academy of Dermatology 1987; 17:866
HSL3420
Collier J, Herxheimer A.
Roussel convicted of misleading promotion
Lancet 1987; 1:113-114
HSL3424
Fisherow WB.
The shape of prescription drug advertising: a survey of promotional techniques and regulatory trends
Food Drug Cosmetic Law Journal 1987; 42:213-236
HSL3425
Freeman JW, Kaatz B.
The physician and the pharmaceutical detail man: an ethical analysis
Journal of Medical Humanities and Bioethics 1987; 8:34-39
HSL3426
Gluck ME, Blumenthal D, Stoto MA.
University-industry relationships in life sciences: Implications for students and post-doctoral fellows
Research Policy 1987; 16:327-336
HSL3430
Gray BV.
Drug promotion
New Zealand Medical Journal 1987; 100:754
HSL3431
Greenhalgh T.
Drug prescription and self-medication in India: an exploratory survey.
Soc Sci Med 1987; 25:(3):307-18
HSL3433
Hancher L.
Regulating drug promotion: the UK experience
Journal of Consumer Policy 1987; 10:383-407
HSL3439
Hutcheon L, Hutcheon M.
Medical “mythologies”: a semiotic approach to pharmaceutical marketing
Queen’s Quarterly 1987; 94:(4):904-916
HSL3440
Johnstone JM.
Special problems in direct-to-consumer advertising of prescription drugs
Food Drug Cosmetic Law Journal 1987; 42:315-322
HSL3451
Lexchin J.
Pharmaceutical promotion in Canada: convince them or confuse them.
Int J Health Serv 1987; 17:(1):77-89
HSL3452
Lidstone J.
Marketing planning for the pharmaceutical industry
1987;
HSL3453
Mahady JM.
Frequent-flyer programs for drug prescribing
New England Journal of Medicine 1987; 317:252
HSL3455
Moulds RF, Wing IM, Shenfield GM, Day RO.
Drug advertising
Medical Journal of Australia 1987; 147:160
HSL3456
Palmer WH, Ross DL.
Introducing a new drug into your practice
Canadian Family Physician 1987; 33:2529-2533
HSL3457
Perri M, Dickson WM.
Direct to consumer prescription drug advertising: consumer attitudes and physician reaction
Journal of Pharmaceutical Marketing & Management 1987; 2:(1):3-25
HSL3458
Roberts WC.
Some realities of present-day cardiologic journal publishing in the USA.
Cardiology 1987; 74:(4):254-62
HSL3462
Singleton SW.
Promoting Retrovir
New England Journal of Medicine 1987; 317:1160
HSL3463
Smith R.
In delicto flagrante
Medical Journal of Australia 1987; 146:322-323
HSL3464
Smith RN.
Role of the pharmaceutical industry in major clinical trials
Lancet 1987; 2:1464
HSL3467
Squires BP.
In whose service?
Canadian Medical Association Journal 1987; 137:983
HSL3469
Szuba TJ.
Drug promotion under the magnifying glass
Journal of Social and Administrative Pharmacy 1987; 4:77-80
HSL3471
Vere DW.
Advertising claims and the Medicines Act
Lancet 1987; 1:278
HSL3472
Wall DW.
Ethics and the pharmaceutical industry: some ideas for general practitioners
Journal of the Royal College of General Practitioners 1987; 37:267-269
HSL3475
Weston-davies WH.
Advertising claims and the Medicines Act
Lancet 1987; 1:278
HSL3477
Wolffers I.
Drug information and sale practices in some pharmacies of Colombo, Sri Lanka.
Soc Sci Med 1987; 25:(3):319-21
HSL3478
Yellin AK.
FDA prescription drug enforcement policies and techniques
Food Drug Cosmetic Law Journal 1987; 42:552-558
HSL3521
Tucker GK, Smith MC.
Direct-to-consumer advertising: Effects of different formats of warning information disclosure on cognitive reactions of adults
Journal of Pharmaceutical Marketing & Management 1987; 2:(1):27-41
HSL9589
Baum C, Faich GA, Anello C, Forbes MB.
Differences in manufacturer reporting of adverse drug reactions to the FDA in 1984
Drug Information Journal 1987; 21:(3):257-266
HSL16715
Wolfe S
Letter to the Editor on Suprofen-induced flank pain and renal failure.
NEJM 1987; 316:1025
HSL16716
Wolfe S
Dangerous Delays in Tampon Absorbency Warnings
JAMA 1987; 258:949
HSL3410
Griffin JP.
Conduct of research on amrinone.
Lancet 1986 Dec 20-27; 2:(8521-22):1462
HSL9615
White JP.
New prescription product lineup looking awesome
Drug Topics 1986 Dec 15; 130:65-66, 68
HSL3339
Evans KR, Beltramini RF.
Physician acquisition of prescription drug information.
J Health Care Mark 1986 Dec; 6:(4):15-25
HSL3408
Re: the promotion of amidopyrine/phenylbutazone/prednisolone
1986 Dec;
HSL3382
Wilmshurst P.
Policing the drug industry.
Lancet 1986 Nov 29; 2:(8518):1280-1
HSL9626
Anderson HJ.
More physicians dispensing commonly prescribed drugs.
Mod Healthc 1986 Nov 21; 16:(24):46
HSL9616
Robinson B.
Diversion bill derailed by sampling controversy
Drug Topics 1986 Nov 3; 130:68
HSL3403
Doctors and the drug industry [Editor's response to 3rd letter (O'Dowd & Whibley)]
British Medical Journal 1986 Nov 1; 293:1171
HSL3404
Fakes RW.
Doctors and the drug industry [2nd of 4 letters]
British Medical Journal 1986 Nov 1; 293:1170-1171
HSL3405
Lenox-smith I, Clifford JM.
Doctors and the drug industry [4th of 4 letters]
British Medical Journal 1986 Nov 1; 293:1171
HSL3406
O'Dowd TC, Whibley R.
Doctors and the drug industry [3rd of 4 letters]
British Medical Journal 1986 Nov 1; 293:1171
HSL3407
Wilkie CE.
Doctors and the drug industry [1st of 4 letters]
British Medical Journal 1986 Nov 1; 293:1170
HSL3400
MLAM letter follow up—Pfizer
MLAM Newsletter 1986 Nov;
HSL3401
Re: the promotion of arsenic/strychnine
1986 Nov;
HSL3402
Ford AR.
“When women outlive their ovaries”
New Internationalist 1986 Nov; (165):12-13
HSL9618
Colombini A.
Health advertising
Notiz Chim Farm 1986 Nov; 25:15
HSL9624
Wade RC.
Promotional group sessions: focus groups that sell
Pharmaceutical Executive 1986 Nov; 6:32, 34
HSL3319
Where to draw the line.
Lancet. 1986 Oct 11; 2:(8511):849
HSL3374
Smith R.
Doctors and the drug industry: too close for comfort.
Br Med J (Clin Res Ed) 1986 Oct 11; 293:(6552):905-6
HSL9605
Weiss B.
What's the FTC up to? State boards want to know!
Drug Topics 1986 Oct 6; 130:32, 34
HSL3371
The relationship between physicians and the pharmaceutical industry: A report of the Royal College of Physicians.
J R Coll Physicians Lond 1986 Oct; 20:(4):235-42
HSL3397
MLAM letter follow up—Parke Davis/Warner Lambert
MLAM Newsletter 1986 Oct;
HSL3398
Re: the promotion of oral streptomycin/chloramphenicol combination
1986 Oct;
HSL3399
Greenhalgh T.
Beneath cosmetic reforms
HAI News 1986 Oct;
HSL9625
Saks DF.
Today's trends to spur drug industry growth
US Pharmacist 1986 Oct; 11:12-16, 20-22
HSL14671
Kissane K.
Drug firm's offer to doctors under fire
National Times 1986 Sep 28
HSL9627
Robinson B.
Dingell keeps fuse burning on sampling practices bomb
Drug Topics 1986 Sep 1; 130:28-29
HSL9628
Weiss B.
Bar codes are here: Burroughs Wellcome makes first move
Drug Topics 1986 Sep 1; 130:72
HSL3394
Re: the promotion of amrinone
1986 Sep;
HSL3395
Re: the promotion of furazolidone/kaolin/pectin
1986 Sep;
HSL3396
Lexchin J.
Good health?
New Outlook 1986 Sep-Oct; 24-26, 28-31
HSL9599
Robbins J.
Pharmacy affairs: making the marketing connection
Pharmaceutical Executive 1986 Sep; 6:40, 42, 44
HSL9622
Seltzer SM.
Electronic bulletin boards for RPh's will proliferate
American Druggist 1986 Sep; 194:116, 119
HSL9633
Unfair sales act upheld
National Association of Retail Druggists Journal 1986 Sep; 108:36-40
HSL9635
Vitriolic anti-generic campaigns held unwarranted
American Pharmacy 1986 Sep; 26:16-17
HSL9621
Smith GT.
Use of generic medicines and importance of brand names. Part 2. Importance of brand names for pharmaceutical innovation
Pharmaceutical Journal 1986 Aug 30; 237:242-243
HSL3366
Musher DM, Young EJ, Hamill RJ.
The ethics of pharmaceutical promotion.
N Engl J Med 1986 Aug 28; 315:(9):590
HSL3344
Holmes J, Hornblow A, Logan W, Botting C, Wells E, Tan SP, Chetwynd J, Frampton C.
Offensive advertising?
N Z Med J 1986 Aug 27; 99:(808):641-2
HSL3379
Taylor D.
Effects of medical research on life expectancy.
Lancet 1986 Aug 16; 2:(8503):399-400
HSL3377
St George D.
Life expectancy, truth, and the ABPI.
Lancet 1986 Aug 9; 2:(8502):346
HSL3365
Moulds RF, Bochner F, Wing LM.
Drug advertising.
Med J Aust 1986 Aug 4-18; 145:(3-4):178-9
HSL9631
Robinson B.
Industry moves to control its own sampling destiny
Drug Topics 1986 Aug 4; 130:22
HSL3392
Re: the promotion of piroxicam
1986 Aug;
HSL3393
Shugar GS.
Mixed opinions on direct-to-consumer advertising
Medical Marketing & Media 1986 Aug; 21:(8):36-38, 40-41
HSL9630
Shugar GR.
Mixed opinions on direct-to-consumer advertising
Medical Marketing and Media 1986 Aug; 21:37-38, 40-41
HSL9634
Davis DA.
FDA becoming sensitive to anti-generic campaign
Drug Cosmet Ind 1986 Aug; 139:30, 32, 35
HSL9637
Hadeler F.
Should expiration dates be required on patients' prescription labels?
Am Pharm 1986 Aug; NS26:(8):30-5
HSL9640
De-mino L.
How Peoples Drug chain helps patrons take medicines properly
Pharmacy Times 1986 Aug; 52:36-38
Page 5 of 11 pages ‹ First < 3 4 5 6 7 > Last ›
